Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAssura Regulatory News (AGR)

Share Price Information for Assura (AGR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 40.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.06 (0.15%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 40.00
AGR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of Chief Financial Officer

4 Aug 2017 07:00

RNS Number : 0712N
Assura PLC
04 August 2017
 

 

4 August 2017

 

Assura plc

 

Appointment of Chief Financial Officer

 

Assura plc ("Assura" or the "Company"), the leading investor and developer of primary care properties, is pleased to announce the appointment of Jayne Cottam to the Board as Chief Financial Officer ("CFO"). Jayne is expected to join the Company before the end of October 2017. Jonathan Murphy has continued to fulfil the role of CFO since his appointment earlier this year as Chief Executive Officer ("CEO") and will do so until Jayne joins Assura.

Jayne, a CIMA qualified accountant, joins Assura from one of the UK's largest private national housing developers. She is currently the Finance Director for Operations, heading up the operational finance team across the group and providing financial and strategic support as a member of the board for each of the three operating regions. Jayne was previously Director of Finance for the Continental Europe Division of European Metal Recycling Limited, one of the worlds' largest metal recyclers, and before that held a number of other senior finance positions.

Jonathan Murphy, CEO of Assura, commented:

"I am delighted that Jayne Cottam will be joining Assura as Chief Financial Officer. Jayne brings a wealth of relevant experience and her financial expertise will prove extremely valuable as we continue to deliver shareholder value and pursue our strategy of investing to support the UK's primary healthcare infrastructure."

Commenting on her appointment, Jayne Cottam said:

"Assura has built a strong business with many opportunities for further growth in a still-developing sector. I am very excited to be joining the Company and look forward to working with Jonathan and the team in helping to support the NHS in providing them with the buildings they need today for the NHS of the future."

There are no further disclosures required pursuant to paragraph 9.6.13 of the Listing Rules.

 

- Ends -

 

 

For more information, please contact:

 

Assura plc

 

Tel: 01925 420660

Jonathan Murphy

 

Orla Ball

 

 

Finsbury

 

Tel: 0207 251 3801

Gordon Simpson

 

Notes to Editors

Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create innovative property solutions in order to facilitate delivery of high quality patient care in the community. At 31 March 2017, Assura's property portfolio was valued at £1,345 million.

 

 

Further information is available at www.assuraplc.com

 

*EPRA is a registered trademark of the European Public Real Estate Association.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAUGURPRUPMGCW
Date   Source Headline
12th May 201711:00 amRNSNotification of Major Interests in Shares
11th May 20172:46 pmRNSNotification of Major Interests in Shares
2nd May 20177:00 amRNSTotal Voting Rights
18th Apr 20177:00 amRNSScrip Dividend Declaration
11th Apr 20174:29 pmRNSNotification of Major Interest in Shares
24th Mar 20174:15 pmRNSScrip Calculation Price
9th Mar 20177:00 amRNSNotice of Dividend
27th Feb 20177:00 amRNSAppointment of CEO
17th Feb 20173:07 pmRNSNotification of Major Interest in Shares
1st Feb 201712:54 pmRNSTotal Voting Rights
1st Feb 20177:00 amRNSTrading Update
26th Jan 20179:18 amRNSNotification of Major Interest in Shares
18th Jan 20177:00 amRNSNotification of Transaction by PDMR
16th Jan 20177:00 amRNSScrip Dividend Declaration
22nd Dec 20167:00 amRNSScrip Calculation Price
8th Dec 20167:00 amRNSNotice of Dividend
22nd Nov 20167:00 amRNSInterim Results 2016
1st Nov 20167:00 amRNSTotal Voting Rights
21st Oct 20162:37 pmRNSNotification of Major Interest in Shares
19th Oct 20169:00 amRNSNotification of Transaction by PDMR
17th Oct 20167:00 amRNSScrip Dividend Declaration
3rd Oct 20167:00 amRNSAppointment of Interim CEO and director
3rd Oct 20167:00 amRNSTrading Update
22nd Sep 20167:00 amRNSScrip Calculation Price
20th Sep 20165:14 pmRNSNotification of Major Interest in Shares
16th Sep 20163:35 pmRNSNotification of Major Interest in Shares
13th Sep 201611:05 amRNSNotification of transactions by PDMRs
8th Sep 20167:00 amRNSNotice of Dividend
1st Sep 20168:00 amRNSTotal Voting Rights
31st Aug 20164:49 pmRNSExercise of Nil Cost Options under VCP
26th Aug 201611:00 amRNSAdditional Listing
9th Aug 20168:00 amRNSDirector/PDMR Shareholdings
1st Aug 20168:00 amRNSTotal Voting Rights
29th Jul 201611:44 amRNSAnnual Information Update
27th Jul 20168:00 amRNSDirector/PDMR Shareholdings
25th Jul 20168:00 amRNSScrip Dividend Declaration
19th Jul 20164:40 pmRNSResult of AGM
19th Jul 20167:00 amRNSTrading Update
4th Jul 201611:34 amRNSGraham Roberts
30th Jun 20167:00 amRNSScrip Calculation Price
17th Jun 20169:11 amRNSPayment on cessation of directorship
16th Jun 20169:00 amRNSNotice of Dividend
15th Jun 20164:16 pmRNSAnnual Report & Notice of AGM
14th Jun 20167:00 amRNSUpdate statement regarding Graham Roberts
23rd May 20163:48 pmRNSDirector/PDMR Shareholding
18th May 20167:00 amRNSFull Year Results
6th May 20169:34 amRNSNotification of Major Interest in Shares
4th May 20169:01 amRNSTotal Voting Rights
26th Apr 201612:24 pmRNSNotification of Major Interest in Shares
20th Apr 201612:28 pmRNSNotification of Major Interest in Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.